KATELYN CARROLL: Open Payments
NPI 1750851853 · MORGANTOWN, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$464 in 25 payments from 8 companies in 2025. Trend: 2023 $943 · 2024 $332 · 2025 $464
Food & beverage: $464
| Company | Payments | Amount |
|---|---|---|
| Braintree Laboratories, Inc. | 3 | $167 |
| ABBVIE INC. | 15 | $135 |
| GENZYME CORPORATION | 1 | $34 |
| PFIZER INC. | 2 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Madrigal Pharmaceuticals | 1 | $25 |
| Janssen Biotech, Inc. | 1 | $18 |
Products named: SUTAB, CREON, SKYRIZI, DUPIXENT, XELJANZ, ENTYVIO, REZDIFFRA, SUFLAVE.
Industry payments across WV — which companies pay providers there.
